FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/08/020976 [Registered on: 29/08/2019] Trial Registered Prospectively
Last Modified On: 19/05/2020
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Process of Care Changes 
Study Design  Single Arm Study 
Public Title of Study   Developing treatment guidelines for early detection of Heart disease through long-term monitoring of key body vitals. 
Scientific Title of Study   A Non-interventional, Observational Study for potential early detection of Heart disease based on, data analytics, through extended monitoring of key body vitals using a finger wearable wireless device (a ring) 
Trial Acronym  ODS 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Kiron Varghese 
Designation  Professor and Head of Department of Cardiology 
Affiliation  St John’s Medical College and Hospital / Department of Cardiology  
Address  Department Of Cardiology, 3rd Floor St. Johns Medical College Hospital, Sarjapur Road, Koramangala

Bangalore
KARNATAKA
560034
India 
Phone  9845167912  
Fax    
Email  drkiron@hotmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Lumina James BTECH MBA 
Designation  Clinical Research Coordinator 
Affiliation  St John’s Medical College Hospital / Department of Cardiology  
Address  Department Of Cardiology, 3rd Floor St. Johns Medical College Hospital, Sarjapur Road, Koramangala

Bangalore
KARNATAKA
560034
India 
Phone  9740010647  
Fax    
Email  luminajsh@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Kiron Varghese 
Designation  Professor and Head of Department of Cardiology 
Affiliation  St John’s Medical College Hospital, Department of Cardiology  
Address  Department Of Cardiology, 3rd Floor St. Johns Medical College Hospital, Sarjapur Road, Koramangala

Bangalore
KARNATAKA
560034
India 
Phone  918022065615  
Fax    
Email  drkiron@hotmail.com  
 
Source of Monetary or Material Support  
Omnyk India Private Limited Fernhill, Gardens, 46 HSR Layout, Sector 6, Bengaluru, 560102, Karnataka 
 
Primary Sponsor  
Name  Omnyk India Private Limited 
Address  Fernhill, Gardens, 46 HSR Layout, Sector 6, Bengaluru, 560102, Karnataka 
Type of Sponsor  Other [Electronic Industry-Global] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Lumina James  St John’s Medical College Hospital  Cardio Research Unit, Department of Cardiology, 3rd Floor, St. Johns Medical College Hospital, Sarjapur Road, Koramangala
Bangalore
KARNATAKA 
9740010647

luminajsh@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Institutional Ethics committee  Approved 
Jayadeva Institute of Cardiovascular Sciences and Research  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I251||Atherosclerotic heart disease of native coronary artery,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Education and lifestyle changes  Based on individual persons extended monitoring of body vitals, along with medical and family history a personalized program will be developed for life style changes. Checkup at regular interval of 3 months will be done to determine the efficacy of intervention. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1. Patients with a diagnosis for one of the cardiac ailments.
2. Patient willing to sign the consent form. 
 
ExclusionCriteria 
Details  1. Patients with acute illness needing critical care or having a definite psychiatric diagnosis.
2. Pregnant women or nursing mothers.
3. Patients with known skin allergies, or sensitivities to synthetic materials.
4. Any patient, who in the opinion of the investigator, are unlikely to fulfill the study requirements.
5. Patients currently enrolled in or are receiving investigational agents.
6. Patients with other comorbidities that may limit their life expectancy to less than 6 months.
7. Patients receiving pacing therapy (e.g., from a pacemaker); 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Correlation of heart health and continuously monitored (24/7) key body vitals for extended period of time  1, 3 , 6 and 9 months 
 
Secondary Outcome  
Outcome  TimePoints 
Development of predictive analysis Algorithms, enabling new guidelines for the care of heart patients.   6, 9, 12 and 15 months 
 
Target Sample Size   Total Sample Size="1500"
Sample Size from India="1500" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   09/09/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

A Non-interventional, Observational Study for potential early detection of Heart disease based on, data analytics, through extended monitoring of key body vitals.Clinical prediction model (CPM) developed based on long-term monitoring of Key body vitals has a good potential to develop a protocol with the capability to finetune it for personalized prediction. Using this model, we should be able to; increase the probability of desired clinical outcomes, resulting in better care at reduced costs for CVD patients.

 
Close